<i>In Vitro</i> Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China-Reference-Cited by-同舟云学术

In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China

Published:2022-02-23 Issue:1 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Han Renru¹²,Ding Li¹²,Yang Yang¹²,Guo Yan¹²,Yin Dandan¹²,Wu Shi¹²,Zhi Peiyuan¹²,Zhu Demei¹²,Liu Qingmei³,Tan Xiaojuan³,Zhu Yuanju³,Zhang Jay⁴,Li Li³,Hu Fupin¹²^ORCID

Affiliation:

1. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China

2. Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China

3. KBP Biosciences Co. Ltd., Jinan, Shandong, China

4. KBP Biosciences USA Inc., Princeton, New Jersey, USA

Abstract

It is reported that A. baumannii has emerged as an intractable nosocomial pathogen in hospitals especially when it develops resistance to carbapenems and other antibiotics, which limits treatment options and leads to high mortality. In February 2017, the WHO published a list of ESKAPE pathogens designated “priority status” for which new antibiotics are urgently needed.

Funder

National Mega-project for Innovative Drugs

China Antimicrobial Surveillance

Science and Technology Innovation Action Plan of Shanghai Science and Technology Committee

National Natural Science Foundation of China

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01471-21

Reference40 articles.